| [1］ Papenburg J， Boivin G. The distinguishing features of human metapneumovirus and respiratory syncytial virus［J］. Med Virol，2010，20：245-260. [2］ Wendt CH， Hertz MI.Respiratory syncytial virus and parainfl uenza virus infections in the immunocompromised host［J］. Semin Respir Infect，1995， 10： 224-231. [3］ Hall CB， Powell KR， MacDonald NE， et al. Respiratory syncytial virus infection in children with compromised immune function［J］. N Engl J Med， 1986， 315： 77-81. [4］ Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection［J］. Arch Dis Child， 2009， 94： 99-103. [5］ Buckingham SC， Quasney MW， Bush AJ， et al. Respiratory syncytial virus infections in the pediatric intensive care unit： clinical characteristics and risk factors for adverse outcomes［J］. Pediatr Crit Care Med， 2001，2：318-323. [6］ Ghosh S， Champlin RE， Englund J， et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients： combination therapy with aerosolized ribavirin and intravenous immunoglobulin［J］. Bone Marrow Transplant， 2000，25：751-755. [7］ Lazar I， Canaan A， Weibel C， et al . Novel mutations in the respiratory syncytial virus G gene identified in viral isolates from a girl with severe combined immune deficiency treated with intravenous immune globulin［J］. J Clin Virol， 2006，37 ：168-173. [8］ Mentel R ，Wegner U， Bruns R ， et al. Real-time PCR to improve the diagnosis of respiratory syncytial virus infection［J］. J Med Microbiol， 2003，52：893-896. [9］ Anonymous. Update： respiratory syncytial virus activity-United States，1994-5 season. MMWR Morb Mortal Wkly Rep，1994， 43：920-922. [10］ Washburne JF， Bocchini JA Jr， Jamison RM. Summertime respiratory syncytial virus［J］. South Med J， 1992， 85： 579-583. [11］ Kim HW， Arrobio JO， Brandt CD，et al. Epidemiology of respiratory syncytial virus infection in Washington， DC. Importance of the virus in different respiratory tract syndromes and temporal distribution of infection［J］. Am J Epidemiol，1973， 98： 216-225. [12］ Ebbert JO，Limper AH. Respiratory syncytial virus pneumonitis in immunocompromised adults： clinical features and outcome［J］. Respiration ，2005，72：263-269. [13］ Borella L，Webster RG. The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission［J］. Cancer Res， 1971，31： 420-426. [14］ Fishaut M， Tubergen D， McIntosh K. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity （review） ［J］. J Pediatr，1980， 96：179-186. [15］ Cranage MP， Gardner PS. Systemic cell-mediated and antibody responses in infants with respiratory syncytial virus infections［J］. J Med Viro， 1980，5： 161-170. [16］ Schleuning M， Buxbaum-Conradi H， Jaeger G， et al. Intravenous ribavirin for eradication of respiratory syncytial virus（RSV） and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants［J］. Hematol J ，2004，5：135-144. [17］ Khanna N， Widmer AF， Decker M， et al. Respiratory syncytial virus infections in patients with hematological diseases: single-center study and review of the literature［J］. Clin Infect Dis， 2008，46：402-412. |
